| Naureen Majid Adam, MD | |
|
2061 Peachtree Rd Ne, Ste 225, Atlanta, GA 30309-1427 | |
| (404) 554-0633 | |
| (770) 929-9092 |
| Full Name | Naureen Majid Adam |
|---|---|
| Gender | Female |
| Speciality | Pain Medicine - Interventional Pain Medicine |
| Location | 2061 Peachtree Rd Ne, Atlanta, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1518174457 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208VP0014X | Pain Medicine - Interventional Pain Medicine | 050775 (Georgia) | Primary |
| Entity Name | Interventional Spine And Pain Management Center, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518012004 PECOS PAC ID: 2769483031 Enrollment ID: O20070130000066 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Interventional Spine And Pain Management Ambulatory Surgical Center |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1750420147 PECOS PAC ID: 5991809469 Enrollment ID: O20070323000138 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Cpm Surgery Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1376716316 PECOS PAC ID: 8820163454 Enrollment ID: O20080818000131 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Greater Anesthesia Services Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1518128289 PECOS PAC ID: 7810064029 Enrollment ID: O20080930000033 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | West Paces Ambulatory Surgical Center, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1164671558 PECOS PAC ID: 2163586652 Enrollment ID: O20090128000245 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Cpm Surgery Center 2, Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1124277959 PECOS PAC ID: 1759579824 Enrollment ID: O20101216000653 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Mulkey Anesthesiology Associates, Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1417288069 PECOS PAC ID: 6406035583 Enrollment ID: O20110120001157 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Cpmsc Carrollton |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1316233612 PECOS PAC ID: 0244401503 Enrollment ID: O20110916000004 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Ispm Asc At Camp Creek Llc |
|---|---|
| Entity Type | Part B Supplier - Ambulatory Surgical Center |
| Entity Identifiers | NPI Number: 1942548870 PECOS PAC ID: 7810126661 Enrollment ID: O20140128000346 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Entity Name | Bhbd Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1487140893 PECOS PAC ID: 0941550701 Enrollment ID: O20180914002655 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Naureen Majid Adam, MD 3400 Peachtree Rd Ne, Ste 811, Atlanta, GA 30326-1170 Ph: (404) 350-0980 | Naureen Majid Adam, MD 2061 Peachtree Rd Ne, Ste 225, Atlanta, GA 30309-1427 Ph: (404) 554-0633 |
News Archive
Many breast cancer survivors experience fatigue and other debilitating symptoms that persist months to years after their course of treatment has ended.
Anadys Pharmaceuticals, Inc. today announced that ANA598 dosing has been completed in the first dose cohort, 200 mg bid, in an ongoing Phase II study of ANA598 in combination with pegylated interferon and ribavirin (SOC) in HCV patients.
The Board of Directors of Patterson Companies, Inc., today declared the quarterly cash dividend of $0.16 per share. The dividend will be payable on January 24, 2014, to shareholders of record on January 10, 2014.
Nurse burnout leads to higher healthcare-associated infection rates (HAIs) and costs hospitals millions of additional dollars annually, according to a study published in the August issue of the American Journal of Infection Control, the official publication of the Association for Professionals in Infection Control and Epidemiology (APIC).
› Verified 1 days ago
William F Keeton, MD Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 1800 Peachtree St Nw, Suite 400, Atlanta, GA 30309 Phone: 404-351-7654 Fax: 404-609-7605 | |
Mr. Lionel Terry Johnson, OPERATIONS Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 5825 Glenridge Dr Ste 2-212, Atlanta, GA 30328 Phone: 678-939-2749 Fax: 404-256-2627 | |
Beata K. Grochowska, MD Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 2061 Peachtree Rd Ne Ste 225, Atlanta, GA 30309 Phone: 770-929-9033 | |
Dr. Jignesh N Gandhi, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Peachtree St Ne, Suite 400, Atlanta, GA 30309 Phone: 404-351-7654 Fax: 404-609-7605 | |
Dr. Rodrigo A Duralde, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 1800 Peachtree St Nw, Suite 400, Atlanta, GA 30309 Phone: 404-351-7654 Fax: 404-609-7605 | |
William F Garrett Jr., MD Pain Medicine Medicare: Not Enrolled in Medicare Practice Location: 4684 Roswell Rd, Atlanta, GA 30342 Phone: 404-843-4228 | |
Christopher D Taylor, M.D. Pain Medicine Medicare: Accepting Medicare Assignments Practice Location: 5555 Peachtree Dunwoody Rd, Ste G99, Atlanta, GA 30342 Phone: 404-843-3323 Fax: 404-574-5944 |